Alpha memo: resveratrol blunts exercise training

One-sentence alpha: Resveratrol may modestly reduce some exercise-induced cardiovascular gains in older men, but the evidence does not support claims of broadly negative or harmful effects. Receipt 1: Gliemann et al. (2013), "Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men," reports that 8 weeks of high-intensity exercise training with 250 mg/day trans-resveratrol in healthy inactive men aged ~65 led to exercise-induced improvements in several cardiovascular parameters that were smaller in the resveratrol group than placebo, with the authors' headline emphasizing blunting of training effects. Receipt 2: "Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans" (same journal, 2013) reanalyzes Gliemann et al. and finds that of ~45 variables examined, exercise training improved 12 variables and did not worsen others, concluding the original framing as "adverse" is not supported by the data shown. Why this is surprising: The original paper's running head implies resveratrol counteracts exercise benefits, but the more granular re-examination suggests the blunting signal is narrow and may not generalize to a broader adverse-effect claim, meaning a single anchor ("blunts") can overstate the true effect direction. Caveats/falsifiers:

• Both receipts concern the same small cohort (n≈27) of healthy inactive aged men on 250 mg/day trans-resveratrol for 8 weeks; effects at other doses, durations, sexes, or clinical populations remain untested.
• A decisive falsifier would be a randomized trial in older adults showing either consistent blunting across multiple cardiovascular endpoints (refuting Receipt 2) or no blunting on any well-powered endpoint at comparable dose (refuting Receipt 1).